Skip to search formSkip to main contentSkip to account menu

CV 4151

Known as: CV-4151 
National Institutes of Health

Related topics

Related topics

1 relation

Broader (1)

isbogrel

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
1999
1999
Ureteral obstruction reverses glomerular proliferation in immune complex glomerulonephritis.
1991
1991
Randomized trial of a selective inhibitor of thromboxane A2 synthetase, (E)-7-phenyl-7-(3-pyridyl)-6-heptenoic acid (CV-4151), for prevention of restenosis after coronary angioplasty.
A selective inhibitor of thromboxane A2 synthetase, CV-4151, has the unique property of increasing prostacyclin synthesis in… 
1991
1991
Thromboxane (Tx) A2 receptor blockade and TxA2 synthase inhibition alone and in combination: comparison of anti‐aggregatory efficacy in human platelets
1 The present study has compared the relative anti‐aggregatory effect of various compounds which interfere with thromboxane (Tx… 
1990
1990
The role of thromboxane (TX) A2 in rabbit arterial thrombosis induced by endothelial damage.
1989
1989
Endothelin-induced mobilization of Ca2+ and the possible involvement of platelet activating factor and thromboxane A2.
1988
1988
RS-5186, a novel thromboxane synthetase inhibitor with a potent and extended duration of action.
1988
1988
The thromboxane A2/prostaglandin endoperoxide receptor antagonist activity of CV-4151, a thromboxane A2 synthetase inhibitor.
1986
1986
Protective effect of a novel thromboxane synthetase inhibitor, CV-4151, on myocardial damage due to coronary occlusion and reperfusion in the hearts of anesthetized dogs.
The protective effect of a novel thromboxane (TX) synthetase inhibitor, (E)-7-phenyl-7-(3-pyridyl)-6-heptenoic acid (CV-4151), on… 
1986
1986
CV-4151--a potent, selective thromboxane A2 synthetase inhibitor.
1985
1985
Delay of the initiation of hypertension in spontaneously hypertensive rats by CV-4151, a specific thromboxane A2 synthetase inhibitor.
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)